Pfizer sets up Bind auction with $20M stalking horse bid
Pfizer has stepped in to help with Bind Therapeutics’ asset sale, setting a stalking horse bid for its assets at $20 million. That basically sets the floor on the price as Bind – once a promising nanotech company founded by MIT’s Robert Langer – looks to get the best price from an auction.
That auction should now proceed on July 25th, with Bind $BIND looking to wrap up the sale sometime in the third quarter.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.